dc.contributor.author
Zaqout, Sami
dc.contributor.author
Ravindran, Ethiraj
dc.contributor.author
Stoltenburg‐Didinger, Gisela
dc.contributor.author
Kaindl, Angela M.
dc.date.accessioned
2022-01-13T14:31:33Z
dc.date.available
2022-01-13T14:31:33Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/33516
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-33237
dc.description.abstract
Biallelic mutations in the cyclin-dependent kinase 5 regulatory subunit-associated protein 2 gene CDK5RAP2 cause autosomal recessive primary microcephaly type 3 (MCPH3). MCPH is characterized by intellectual disability and microcephaly at birth, classically without further organ involvement. Only recently, congenital cataracts were reported in four patients of one pedigree with MCPH3. Given the lack of a further pedigree with this phenotype, it remained unclear whether this was a true causal relationship. Here we support the link between CDK5RAP2 and eye development by showing that most Cdk5rap2 mutant mice (an/an) exhibit eye malformations ranging from reduced size of one or both eyes (microphthalmia) to total absence of both eyes (anophthalmia). We also detected increased apoptosis in the an/an retinal progenitor cells associated with more mitotic cells. This indicates an important role of Cdk5rap2 in physiologic eye development.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
eye development
en
dc.subject
microcephaly
en
dc.subject
microphthalmia
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Congenital microcephaly‐linked CDK5RAP2 affects eye development
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1111/ahg.12343
dcterms.bibliographicCitation.journaltitle
Annals of Human Genetics
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.pagestart
87
dcterms.bibliographicCitation.pageend
91
dcterms.bibliographicCitation.volume
84
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
31355417
dcterms.isPartOf.issn
0003-4800
dcterms.isPartOf.eissn
1469-1809